Advanced in Primitive Neuroectodermal Tumor (PNET)

Dr. Krishna N. Reddy

Radiation Oncology
Kansas University Physicians Inc
12200 W 110th St, University Of Kansas Hosp, 
Shawnee Mission, KS 
Accepting New Patients
Offers Telehealth
Advanced in Primitive Neuroectodermal Tumor (PNET)
Kansas University Physicians Inc
12200 W 110th St, University Of Kansas Hosp, 
Shawnee Mission, KS 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Krishna Reddy is a Radiation Oncologist in Shawnee Mission, Kansas. Dr. Reddy is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Posterior Fossa Tumor, Astrocytoma, Gliosarcoma, and Embryonal Tumor with Multilayered Rosettes. Dr. Reddy is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in OH
Hospital Affiliations
North Kansas City Hospital
University Of Kansas Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

KANSAS UNIVERSITY PHYSICIANS INC
12200 W 110th St, University Of Kansas Hosp, Shawnee Mission, KS 66210
Other Locations
KANSAS UNIVERSITY PHYSICIANS INC
2750 Clay Edwards Dr, Suite 10, North Kansas City, MO 64116
KANSAS UNIVERSITY PHYSICIANS INC
20333 W 151st St, Olathe Medical Center, Olathe, KS 66061
KANSAS UNIVERSITY PHYSICIANS INC
3901 Rainbow Blvd, Suite 5300, Kansas City, KS 66160
KANSAS UNIVERSITY PHYSICIANS INC
4000 Cambridge St, Suite G600, Kansas City, KS 66160
KANSAS UNIVERSITY PHYSICIANS INC
4350 Shawnee Mission Pkwy, Fairway, KS 66205
KANSAS UNIVERSITY PHYSICIANS INC
12200 W 110th St, Overland Park, KS 66210

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
A Phase II-R and a Phase III Trial Evaluating Both Erlotinib (Ph II-R) and Chemoradiation (Ph III) as Adjuvant Treatment for Patients With Resected Head of Pancreas Adenocarcinoma
Enrollment Status: Completed
Publish Date: October 08, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Capecitabine, Chemotherapy, Erlotinib hydrochloride, Fluorouracil, Gemcitabine hydrochloride
Study Phase: Phase 3
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 30, 2025
Intervention Type: Radiation
Study Phase: Phase 3
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Active_not_recruiting
Publish Date: May 09, 2025
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
A Phase III Randomized, Double-Blind Placebo Controlled Study of Armodafinil (Nuvigil®) To Reduce Cancer-Related Fatigue in Patients With High Grade Glioma
Enrollment Status: Completed
Publish Date: January 27, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase II Trial of Hypofractionated Intensity-Modulated Radiation Therapy (IMRT) Utilizing 2.5 Gy/Fraction to PET-avid Disease Combined With Carboplatin and Paclitaxel for Subjects With Stage IIIA or IIIB Non-Small Cell Lung Cancer
A Phase II Trial of Hypofractionated Intensity-Modulated Radiation Therapy (IMRT) Utilizing 2.5 Gy/Fraction to PET-avid Disease Combined With Carboplatin and Paclitaxel for Subjects With Stage IIIA or IIIB Non-Small Cell Lung Cancer
Enrollment Status: Withdrawn
Publish Date: November 05, 2020
Intervention Type: Drug, Radiation
Study Phase: Phase 2
View 5 Less Clinical Trials

21 Total Publications

Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases - A Case-Based Radiosurgery Society Practice Guide and Review.
Stereotactic Body Radiotherapy for the Treatment of Adrenal Metastases - A Case-Based Radiosurgery Society Practice Guide and Review.
Journal: Practical radiation oncology
Published: May 12, 2025
Similar Doctors
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Fen Wang
Radiation Oncology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Fen Wang
Radiation Oncology

Kansas University Physicians Inc

4000 Cambridge St, 
Kansas City, KS 
 (10.8 miles away)
Languages Spoken:
English, German, Mandarin, Zhuang
See accepted insurances
Accepting New Patients
Offers Telehealth

Fen Wang is a Radiation Oncologist in Kansas City, Kansas. Dr. Wang is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Meningioma, Lung Cancer, Pleuropulmonary Blastoma, and Posterior Fossa Tumor. Dr. Wang is currently accepting new patients.

Advanced in Primitive Neuroectodermal Tumor (PNET)
Dr. Vickie L. Massey
Radiation Oncology
Advanced in Primitive Neuroectodermal Tumor (PNET)
Dr. Vickie L. Massey
Radiation Oncology

Midwest Oncology Associates LLC

2316 E Meyer Blvd, 
Kansas City, MO 
 (10.6 miles away)
816-276-4700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Vickie Massey is a Radiation Oncologist in Kansas City, Missouri. Dr. Massey is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Metastatic Uveal Melanoma, Melanoma of the Eye, Posterior Fossa Tumor, and Choroid Plexus Carcinoma. Dr. Massey is currently accepting new patients.

Advanced in Primitive Neuroectodermal Tumor (PNET)
Dr. Bradley H. Koffman
Radiation Oncology
Advanced in Primitive Neuroectodermal Tumor (PNET)
Dr. Bradley H. Koffman
Radiation Oncology

Midwest Oncology Associates LLC

3889 S Jackson Dr, 
Independence, MO 
 (21.7 miles away)
816-698-8290
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bradley Koffman is a Radiation Oncologist in Independence, Missouri. Dr. Koffman is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Posterior Fossa Tumor, and Anal Cancer. Dr. Koffman is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Reddy's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 49 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile